All of the preferred first-line products named in the table are designated GREEN and are approved for use through the In order to prevent confusion with similar strength unlicensed food supplements, all colecalciferol products should be prescribed by preferred brand name. No treatment necessary Note: The immunoassay used in the Path Links laboratories does not detect D2 (ergocalciferol) or D3 (colecalciferol), instead it measures the 25 hydroxylated metabolite. Level of deficiency level Recommended treatment Severe deficiency (associated with osteomalacia including rickets in children and osteoporosis and fractures in adults) 75nmol/l symptoms, consider lifestyle advice including: increased dietary intake and safe sun exposure (see PACE Bulletin Vol 6 No 6 Prevention of vitamin D deficiency in at-risk groups (May 2012)). The table below identifies different levels of deficiency according to levels and recommends a range of different approaches to treatment dependent upon the level of deficiency. Vitamin D is seasonal, but replete levels should be > 75 nmol/l. This is the level below which parathyroid hormone (PTH) starts to rise causing increased bone turnover and hence the symptoms associated with osteomalacia (these include rickets in children and osteoporosis and fractures in adults).
1 Arden and Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and Lincolnshire Partnership Foundation Trust Volume 9 Number 13 September 2015 TREATMENT OF VITAMIN D DEFICIENCY IN AT-RISK ADULTS (SECOND EDITION) Executive Summary Vitamin D deficiency is normally defined as a concentration of of less than 25nmol/litre.
0 kommentar(er)
